AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11821469 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation (total dose of 54.0 Gy to the tumor region only), n = 7
Number of subjects: 63
Study 10402369 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine treatment
Number of subjects: 34
Study 10402369 — intervention group
Group type: COMPARATOR
Intervention: Flare-up GnRHa plus elevated pFSH (Control)
Number of subjects: 34
Study 7747293 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 ampoules (40 mL) of Brazilian Brothrops polyspecific antivenom
Number of subjects: 340
Study 7747293 — intervention group
Group type: COMPARATOR
Intervention: 2 ampoules (20 mL) of Brazilian Brothrops polyspecific antivenom
Number of subjects: 340
Study 2206784 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg verapamil i.v. (8 patients)
Number of subjects: 20
Study 2206784 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg isosorbide dinitrate sublingually (12 patients)
Number of subjects: 20
Study 2206784 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion (7 patients)
Number of subjects: 20
Study 30461155 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbable subcuticular staples
Number of subjects: 206
Study 30461155 — intervention group
Group type: COMPARATOR
Intervention: Subcuticular suture
Number of subjects: 206
Study 28583024 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health intervention (Reach Out)
Number of subjects: 94
Study 28583024 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 94
Study 27422639 — intervention group
Group type: EXPERIMENTAL
Intervention: iHEART intervention (iPhone® equipped with AliveCor® Mobile ECG and Kardia application, plus motivational text messages)
Number of subjects: 300
Study 27422639 — intervention group
Group type: COMPARATOR
Intervention: Usual cardiac care
Number of subjects: 300
Study 27422639 — intervention group
Group type: EXPERIMENTAL
Intervention: iHEART intervention
Number of subjects: 300
Study 24525963 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics (vancomycin/cefepime or piperacillin/tazobactam)
Number of subjects: 38
Study 24525963 — intervention group
Group type: COMPARATOR
Intervention: No preventive antibiotics (Control)
Number of subjects: 38
Study 22561352 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured one‐to‐one behaviour change programme delivered over 14 visits during 12 months by trained advisors
Number of subjects: 381
Study 22561352 — intervention group
Group type: COMPARATOR
Intervention: Usual care in general practice
Number of subjects: 381
Study 22561352 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured one‐to‐one behaviour change programme
Number of subjects: 381
Study 19789884 — intervention group
Group type: EXPERIMENTAL
Intervention: iobitridol (350 mgI/ml)
Number of subjects: 307
Study 19789884 — intervention group
Group type: COMPARATOR
Intervention: iomeprol (400 mgI/ml)
Number of subjects: 307
Study 18217911 — intervention group
Group type: COMPARATOR
Intervention: Systemic venous drainage (S-SPK group)
Number of subjects: 80
Study 18217911 — intervention group
Group type: EXPERIMENTAL
Intervention: Portal venous drainage (P-SPK group)
Number of subjects: 80
Study 15880744 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal occult blood test (FOBT)
Number of subjects: 628
Study 15880744 — intervention group
Group type: EXPERIMENTAL
Intervention: Sigmoidoscopy/colonoscopy
Number of subjects: 628
Study 15880744 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent FOBT
Number of subjects: 628
Study 15880744 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent sigmoidoscopy/colonoscopy
Number of subjects: 628
Study 12897600 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Form‐36 (SF‐36)
Number of subjects: 0
Study 12897600 — intervention group
Group type: EXPERIMENTAL
Intervention: Musculoskeletal Functional Assessment
Number of subjects: 0
Study 12897600 — intervention group
Group type: EXPERIMENTAL
Intervention: Disability of the Arm, Shoulder and Hand
Number of subjects: 0
Study 12897600 — intervention group
Group type: EXPERIMENTAL
Intervention: Western Ontario McMaster Osteoarthritis Index (WOMAC)
Number of subjects: 0
Study 12897600 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple Shoulder Test
Number of subjects: 0
Study 12897600 — intervention group
Group type: EXPERIMENTAL
Intervention: Roland‐Morris Questionnaire
Number of subjects: 0
Study 12897600 — intervention group
Group type: EXPERIMENTAL
Intervention: Oswestry Disability Index
Number of subjects: 0
Study 10811045 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Therapy Programme (MTP)
Number of subjects: 180
Study 10811045 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Training Programme (ITP)
Number of subjects: 180
Study 10811045 — intervention group
Group type: COMPARATOR
Intervention: General Practitioner Programme (GPP)
Number of subjects: 180
Study 10811045 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment programmes
Number of subjects: 180
Study 8981727 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous blood transfusion
Number of subjects: 1060
Study 8981727 — intervention group
Group type: COMPARATOR
Intervention: Allogeneic blood transfusion
Number of subjects: 1060
Study 1353192 — intervention group
Group type: EXPERIMENTAL
Intervention: 200,000 IU vitamin A and 40 IU vitamin E every 6 months
Number of subjects: 28753
Study 1353192 — intervention group
Group type: COMPARATOR
Intervention: 40 IU vitamin E alone (placebo group)
Number of subjects: 28753
Study 6091244 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTH 1‐17 (100 micrograms i.v.)
Number of subjects: 40
Study 6091244 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 30698049 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive swallowing exercise program (3 weekly supervised sessions of 30 min each and home-based exercises 3 times daily)
Number of subjects: 45
Study 29937396 — intervention group
Group type: EXPERIMENTAL
Intervention: Outcome feedback intervention group
Number of subjects: 2233
Study 29937396 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual control group
Number of subjects: 2233
Study 26667088 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin-calcitriol-calcium treatment
Number of subjects: 427
Study 26667088 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger subjects (aged 50 years or less)
Number of subjects: 427
Study 26667088 — intervention group
Group type: EXPERIMENTAL
Intervention: Older subjects (aged over 70 years)
Number of subjects: 427
Study 26667088 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 427
Study 26667088 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of adenomas at inclusion
Number of subjects: 427
Study 24899158 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein (HP) diet (37.7 en% fat, 25.7 en% protein, 36.6 en% carbohydrates)
Number of subjects: 27
Study 24899158 — intervention group
Group type: COMPARATOR
Intervention: Normal-protein (NP) diet (39.4 en% fat, 15.4 en% protein, 45.2 en% carbohydrates)
Number of subjects: 27
Study 22934397 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal acupuncture needle muscular stimulation therapy, conducted once a week for 4 weeks.
Number of subjects: 120
Study 22934397 — intervention group
Group type: COMPARATOR
Intervention: Celebrex (200 mg, once daily for 4 weeks)
Number of subjects: 120
Study 20058569 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml/kg of Ringer's lactate
Number of subjects: 80
Study 20058569 — intervention group
Group type: COMPARATOR
Intervention: 10 ml/kg of Ringer's lactate
Number of subjects: 80
Study 17415686 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbomer-based artificial tears
Number of subjects: 67
Study 17415686 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellulose-based artificial tears
Number of subjects: 67
Study 17415686 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral oil-based artificial tears
Number of subjects: 67
Study 16319703 — intervention group
Group type: EXPERIMENTAL
Intervention: Loose criterion condition (presence/absence judgments)
Number of subjects: 160
Study 16319703 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict criterion condition (reading aloud every detected word)
Number of subjects: 160
Study 12481630 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial therapy with dexamethasone 0.6 mg/kg/day in 3 divided doses for 4 days
Number of subjects: 68
Study 12481630 — intervention group
Group type: COMPARATOR
Intervention: Antimicrobial therapy alone (benzyl penicillin and chloramphenicol for 14 days)
Number of subjects: 68
Study 9818338 — intervention group
Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate 0.5%
Number of subjects: 227
Study 9818338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 227
Study 7649710 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic fatigue test to 50% MVC, repeated 3 times
Number of subjects: 16
Study 7649710 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery immediately following fatigue exercise (Group 1)
Number of subjects: 16
Study 7649710 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery between 3 and 6 minutes (Group 2)
Number of subjects: 16
Study 7649710 — intervention group
Group type: EXPERIMENTAL
Intervention: No recovery during the 8 minute period (Group 3)
Number of subjects: 16
Study 2565773 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group (n = 21)
Number of subjects: 31
Study 2565773 — intervention group
Group type: COMPARATOR
Intervention: Non-training group (n = 10)
Number of subjects: 31
Study 10941 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrazepam (10 mg)
Number of subjects: 0
Study 10941 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam hydrochloride (30 mg)
Number of subjects: 0
Study 10941 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentobarbitone sodium (200 mg)
Number of subjects: 0
Study 10941 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30951004 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary resuscitation coach
Number of subjects: 200
Study 30951004 — intervention group
Group type: COMPARATOR
Intervention: No cardiopulmonary resuscitation coach
Number of subjects: 200
Study 30951004 — intervention group
Group type: EXPERIMENTAL
Intervention: Roles within teams with a cardiopulmonary resuscitation coach
Number of subjects: 200
Study 28213957 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg kg‐1 b.i.d.
Number of subjects: 64
Study 28213957 — intervention group
Group type: COMPARATOR
Intervention: 2 mg kg‐1 t.i.d.
Number of subjects: 64
Study 26742977 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar cautery technique
Number of subjects: 200
Study 26742977 — intervention group
Group type: COMPARATOR
Intervention: Ligation technique
Number of subjects: 200
Study 23242192 — intervention group
Group type: EXPERIMENTAL
Intervention: Home monitoring (HM) of ICD, patients seen once a year unless dysfunction or clinical event occurs.
Number of subjects: 433
Study 23242192 — intervention group
Group type: COMPARATOR
Intervention: Ambulatory follow-ups, patients seen every 6 months.
Number of subjects: 433
Study 23242192 — intervention group
Group type: EXPERIMENTAL
Intervention: Home monitoring (HM) of ICD.
Number of subjects: 433
Study 21682833 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin 12.5 mg added to pioglitazone
Number of subjects: 0
Study 21682833 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin 25 mg added to pioglitazone
Number of subjects: 0
Study 21682833 — intervention group
Group type: COMPARATOR
Intervention: Placebo added to pioglitazone
Number of subjects: 0
Study 21682833 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin (12.5 or 25 mg) during the 40-week extension
Number of subjects: 0
Study 18272504 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 1012
Study 18272504 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 1012
Study 18272504 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 1012
Study 15743867 — intervention group
Group type: EXPERIMENTAL
Intervention: Twin Block (TB) mandibular advancement splint
Number of subjects: 16
Study 15743867 — intervention group
Group type: COMPARATOR
Intervention: Herbst mandibular advancement splint (MAS)
Number of subjects: 16
Study 11836292 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human GH therapy at 27 IU (9 mg)/m(2) x wk
Number of subjects: 58
Study 11836292 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human GH therapy at 18 IU (6 mg)/m(2) x wk
Number of subjects: 58
Study 11836292 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 58
Study 10343539 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiperinuclear factor (APF)
Number of subjects: 279
Study 10343539 — intervention group
Group type: EXPERIMENTAL
Intervention: Antikeratin antibodies (AKA)
Number of subjects: 279
Study 10343539 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibodies to human epidermis filaggrin (AFA)
Number of subjects: 279
Study 10343539 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of APF and AKA
Number of subjects: 279
Study 10343539 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of AFA and AKA
Number of subjects: 279
Study 8960842 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight control (systolic < 150/diastolic < 85 mmHg) with beta blocker (atenolol) or ACE inhibitor (captopril)
Number of subjects: 758
Study 8960842 — intervention group
Group type: COMPARATOR
Intervention: Less tight control (systolic < 180/diastolic < 105 mmHg)
Number of subjects: 758
Study 8960842 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 758
Study 8960842 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 758
Study 8960842 — intervention group
Group type: EXPERIMENTAL
Intervention: Both atenolol and captopril
Number of subjects: 758
Study 8960842 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight control (atenolol or captopril)
Number of subjects: 758
Study 8960842 — intervention group
Group type: COMPARATOR
Intervention: Less tight control
Number of subjects: 758
Study 2022136 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant-parent psychotherapy (intervention lasted 1 year, ending when the child was 24 months)
Number of subjects: 2
Study 2022136 — intervention group
Group type: COMPARATOR
Intervention: Secure control group (no intervention)
Number of subjects: 2
Study 2022136 — intervention group
Group type: COMPARATOR
Intervention: Anxious controls (no intervention)
Number of subjects: 2
Study 6819904 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral TRH (20 mg twice daily)
Number of subjects: 10
Study 6819904 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral metoclopramide (10 mg t.d.s.)
Number of subjects: 10
Study 6819904 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29855782 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed reduction and percutaneous Kirschner wire fixation (K wire)
Number of subjects: 32
Study 29855782 — intervention group
Group type: COMPARATOR
Intervention: Open reduction and internal fixation with mini fragment plates
Number of subjects: 32
Study 29029687 — intervention group
Group type: EXPERIMENTAL
Intervention: Net‐COPD telemedicine intervention with weekly submission of readings and regular video consultations
Number of subjects: 14
Study 26026209 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fiber (total, soluble and insoluble)
Number of subjects: 40
Study 26026209 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-fiber index (ratio of protein to fiber)
Number of subjects: 40
Study 25010882 — intervention group
Group type: EXPERIMENTAL
Intervention: fast‐setting addition‐curing silicone (AS)
Number of subjects: 96
Study 25010882 — intervention group
Group type: EXPERIMENTAL
Intervention: fast‐setting polyether (PE)
Number of subjects: 96
Study 25010882 — intervention group
Group type: EXPERIMENTAL
Intervention: fast‐setting PE material
Number of subjects: 96
Study 25010882 — intervention group
Group type: EXPERIMENTAL
Intervention: fast‐setting AS and PE materials
Number of subjects: 96
Study 22334770 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate/formoterol fumarate (MF/F) 400/10 μg
Number of subjects: 2251
Study 22334770 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate/formoterol fumarate (MF/F) 400/10 μg, MF 400, F 10
Number of subjects: 2251
Study 22334770 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate/formoterol fumarate (MF/F) groups
Number of subjects: 2251
Study 22334770 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate/formoterol fumarate (MF/F) 400/10 μg, MF/F 200/10 μg
Number of subjects: 2251
Study 22334770 — intervention group
Group type: EXPERIMENTAL
Intervention: All active treatment groups
Number of subjects: 2251
Study 22334770 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 2251
Study 19173751 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 0
Study 19173751 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 0
Study 19173751 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 0
Study 19173751 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV
Number of subjects: 0
Study 17318620 — intervention group
Group type: EXPERIMENTAL
Intervention: Avaxim 80
Number of subjects: 424
Study 17318620 — intervention group
Group type: EXPERIMENTAL
Intervention: Havrix 720
Number of subjects: 424
Study 17318620 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaqta 25
Number of subjects: 424
Study 17318620 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of the same vaccine
Number of subjects: 424
Study 17318620 — intervention group
Group type: COMPARATOR
Intervention: Local and systemic adverse events
Number of subjects: 424
Study 15220672 — intervention group
Group type: EXPERIMENTAL
Intervention: Orally consumed lactobacilli isolated from the vagina
Number of subjects: 0
Study 15220672 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 11171873 — intervention group
Group type: EXPERIMENTAL
Intervention: At least 2.5 servings/day of vegetables
Number of subjects: 15220
Study 11171873 — intervention group
Group type: EXPERIMENTAL
Intervention: Each additional serving/day of vegetables
Number of subjects: 15220
Study 11171873 — intervention group
Group type: EXPERIMENTAL
Intervention: At least 2.5 servings/day of vegetables among men with BMI >= 25
Number of subjects: 15220
Study 11171873 — intervention group
Group type: EXPERIMENTAL
Intervention: At least 2.5 servings/day of vegetables among current smokers
Number of subjects: 15220
Study 9787142 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone (0.3 mg/kg every 12 hours x 4 doses)
Number of subjects: 38
Study 9787142 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone
Number of subjects: 38
Study 9787142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 7636912 — intervention group
Group type: EXPERIMENTAL
Intervention: High Albumin (supplemental albumin to maintain levels 2.5 to 3.5 g/dL)
Number of subjects: 70
Study 7636912 — intervention group
Group type: COMPARATOR
Intervention: Low Albumin (albumin only if levels dropped < 1.5 g/dL)
Number of subjects: 70
Study 7636912 — intervention group
Group type: EXPERIMENTAL
Intervention: High Albumin
Number of subjects: 70
Study 7636912 — intervention group
Group type: COMPARATOR
Intervention: Low Albumin
Number of subjects: 70
Study 2521103 — intervention group
Group type: EXPERIMENTAL
Intervention: Respite or educational services
Number of subjects: 541
Study 2521103 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 541
Study 237493 — intervention group
Group type: EXPERIMENTAL
Intervention: Alclofenac 3 g
Number of subjects: 31
Study 237493 — intervention group
Group type: COMPARATOR
Intervention: Phenylbutazone 300 mg
Number of subjects: 31
Study 30859363 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline supplementation (30 mg/kg/day)
Number of subjects: 24
Study 30859363 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (60 mg/kg/day)
Number of subjects: 24
Study 30859363 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined choline and DHA supplementation
Number of subjects: 24
Study 30859363 — intervention group
Group type: COMPARATOR
Intervention: Standard nutrition (control)
Number of subjects: 24
Study 31227681 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose wide-detector scan (experimental group)
Number of subjects: 90
Study 31227681 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose helical scan (low-dose helical group)
Number of subjects: 90
Study 31227681 — intervention group
Group type: COMPARATOR
Intervention: Pediatric conventional scan (conventional group)
Number of subjects: 90
Study 28698884 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 1167
Study 28698884 — intervention group
Group type: COMPARATOR
Intervention: IFG
Number of subjects: 1167
Study 28698884 — intervention group
Group type: COMPARATOR
Intervention: Normoglycaemia
Number of subjects: 1167
Study 25646186 — intervention group
Group type: EXPERIMENTAL
Intervention: Meaning-centered group psychotherapy (MCGP)
Number of subjects: 253
Study 25646186 — intervention group
Group type: COMPARATOR
Intervention: Supportive group psychotherapy (SGP)
Number of subjects: 253
Study 23570342 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic women
Number of subjects: 184
Study 23570342 — intervention group
Group type: COMPARATOR
Intervention: Non-diabetic women
Number of subjects: 184
Study 23570342 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmenopausal diabetic females
Number of subjects: 184
Study 23570342 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic females
Number of subjects: 184
Study 21742349 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert-guided tutorial combined with self-directed practice on a procedural trainer
Number of subjects: 39
Study 21742349 — intervention group
Group type: COMPARATOR
Intervention: Expert-guided simulator training alone
Number of subjects: 39
Study 19184087 — intervention group
Group type: EXPERIMENTAL
Intervention: One-running-session trial (T1) - 10 x 1 km interval repeats (90% peak VO2 velocity)
Number of subjects: 10